Clinical Research in Orthopedics

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

matadorbet grandpashabet betist bahsegel klasbahis jasminbet hepsi bahis dinamobet betvole betpark betlike betboo sultanbet tulipbet padisahbet savoybetting goldenbahis maksibet fenomenbet jojobet tarafbet

Veljko Kopjar Author

Subjects of specialization
Musculoskeletal biology, Cubosomal gel, Orthopaedics, Rickets

Affiliation
Director of Clinical Development, Clinipace Worldwide, Inc. North Carolina, USA

Biography

Veljko Kopjar was working as a Director of Clinical Development, Clinipace Worldwide, Inc. North Carolina, USA. He has more than 50 publications. His current research in  Medical Devices used in the United States are FDA-Approved. 
 


Publications

Editorial Open Access

A Broken Regulatory System: Only 2% of Medical Devices used in the United States are FDA-Approved

Author(s):

Veljko Kopjar

When most people think of medical devices that are legally marketed in the United States and implanted or otherwise used by trained and licensed surgeons, they are very likely thinking of FDAApproved medical devices. FDA Approval incorporates rigorous preclinical research such as: cadaver, animal, mechanical, materials and stress testing followed by human subject trials that are aimed at proving that a device is safe and effective. The trials may include a pivotal trial preceded by one or more pilot studies, and an adequate number of months for clinical follow-up. Many devices (e.g., hipreplacement systems) usually require at least 24 months’ follow-up. In order for a company to pursue this pathway, it must first obtain an Investigational Device Exemption (IDE) which allows it to ... view moreĀ»

Abstract HTML PDF



Google Scholars / Researchers Sites

GET THE APP